Anti-angiogenic treatment of gastrointestinal malignancies (Q36353516)

13 August 2017

1 reference

title

Anti-angiogenic treatment of gastrointestinal malignancies (English)

1 reference

13 August 2017

main subject

angiogenesis inhibitor

1 reference

J Stuart Salmon

1

1 reference

13 August 2017

A Craig Lockhart

series ordinal

2

1 reference

13 August 2017

Jordan Berlin

series ordinal

3

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

23

1 reference

13 August 2017

issue

8

1 reference

13 August 2017

page(s)

712-726

1 reference

Tumor angiogenesis: therapeutic implications

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Molecular basis of angiogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Tumor dormancy in vivo by prevention of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Regulation of angiogenesis by hypoxia: role of the HIF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Promises and pitfalls of anti-angiogenic therapy in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

VEGF-receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Structural analysis of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular permeability factor (VPF, VEGF) in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Angiogenesis inhibitors in clinical development; where are we now and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular-targeting therapies for treatment of malignant disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

VEGF-Trap: a VEGF blocker with potent antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Antitumor effect on human gastric cancer and induction of apoptosis by vascular endothelial growth factor neutralizing antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Prognostic value of VEGF in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant and malignant hepatic nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500360024

10.1080/07357900500360024

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference